← back to search

Marilena Marcosano

Università Campus Bio-Medico · IT
Area of research
Psychiatry and Mental health · Neurology
Research interest
Research interests include Medicine, Migraine, Chronic Migraine, Calcitonin gene-related peptide, Internal medicine, and Stroke (engine).
h-index
citations
122
works
24
NIH funding
primary concept
email

Recent publications

OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study
Toxins 2026cited by 0position: middledoi
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Cephalalgia 2026cited by 0position: middledoi
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)
Frontiers in Neurology 2026cited by 0position: middledoi
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study)
Cephalalgia 2025cited by 14position: middledoi
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)
The Journal of Headache and Pain 2025cited by 4position: middledoi
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments
Cephalalgia 2025cited by 1position: middledoi
Anti-CGRP monoclonal antibodies and migraine with aura: a narrative review
Confinia cephalalgica. 2025cited by 0position: middledoi
Enlarged perivascular spaces as vascular health indicators: correlations with clinical and imaging data in young and middle-age stroke patients
Neuroradiology 2025cited by 0position: middledoi
Introducing the Four Dimensions 4D Migraine Scale: A Composite Score Proposal Evaluating Migraine Severity and Treatment Efficacy
Epidemiology Biostatistics and Public Health 2025cited by 0position: middledoi
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy
Cephalalgia 2025cited by 0position: middledoi
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
The Journal of Headache and Pain 2024cited by 23position: middledoi
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study
Toxins 2024cited by 5position: middledoi
Acute medications’ intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center
Frontiers in Neurology 2024cited by 4position: middledoi
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study
Journal of Stroke and Cerebrovascular Diseases 2024cited by 3position: middledoi
The perivascular spaces in young and middle-aged stroke: A single-center analysis integrating clinical and Doppler ultrasound findings
The Neuroradiology Journal 2024cited by 2position: middledoi
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life
Neurological Sciences 2024cited by 1position: middledoi
Diaphragmatic small bowel disease in a patient with resistant migraine and medication overuse treated with galcanezumab
Confinia cephalalgica. 2024cited by 1position: firstdoi
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles—A Narrative Review
International Journal of Molecular Sciences 2023cited by 23position: middledoi
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review
Therapeutics and Clinical Risk Management 2023cited by 9position: middledoi
Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study
Toxins 2023cited by 7position: middledoi
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura
Frontiers in Neurology 2023cited by 3position: middledoi
Uhthoff Phenomenon in Guillain Barré Syndrome
Neurology India 2023cited by 0position: middledoi
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness
International Journal of Environmental Research and Public Health 2022cited by 14position: middledoi
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment
Headache The Journal of Head and Face Pain 2022cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fabrizio Vernieri · McMaster University20 papers (2022–2026)Claudia Altamura · McMaster University18 papers (2022–2025)Nicoletta Brunelli · Università Campus Bio-Medico14 papers (2022–2026)Luisa Fofi · Università Campus Bio-Medico11 papers (2022–2026) · 6 papers (2024–2026) · 5 papers (2025–2026)Mauro Silvestrini · McMaster University4 papers (2023–2025)Alessandro Alesina · Università Campus Bio-Medico4 papers (2023–2025) · 3 papers (2025–2026)Gabriele Sebastianelli · Università Campus Bio-Medico3 papers (2025–2026)Giovanna Viticchi · Università Campus Bio-Medico3 papers (2023–2025) · 3 papers (2024–2025)Carlo Augusto Mallio · Università Campus Bio-Medico3 papers (2024–2025) · 2 papers (2025–2025) · 2 papers (2025–2026)Adriano Bonura · Università Campus Bio-Medico2 papers (2023–2024) · 2 papers (2025–2025)Caterina Bernetti · Università Campus Bio-Medico2 papers (2024–2025) · 2 papers (2024–2025)Carmelina Maria Costa · Università Campus Bio-Medico2 papers (2022–2024)